Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Microbes Infect. 2008 Jul 17;10(12-13):1244–1250. doi: 10.1016/j.micinf.2008.07.021

Fig. 1.

Fig. 1

Mice were pretreated with peptidoglycan (PGN) for 2 consecutive days and subsequently challenged with live Pseudomonas aeruginosa 2 days after the second PGN dose. Blood samples were collected 6 hours after the Pseudomonas challenge, and plasma concentrations of IFNγ, TNFα, and IL-10 were determined by ELISA. (* indicates p<0.05 vs control, N= 5 per group).